Dottie Koulermos

Credit Manager at Chembio Diagnostics - Medford, NY, US

Dottie Koulermos's Colleagues at Chembio Diagnostics
Annette Ortiz

Quality Assurance Analyst

Contact Annette Ortiz

Ehsan Bagherzadeh

Hardware and Software Developer

Contact Ehsan Bagherzadeh

Chuck Caso

Vice President, Sales & Marketing

Contact Chuck Caso

Melissa Gallagher

Director - Reporting, Financial Planning & Analysis

Contact Melissa Gallagher

Sandy Speer

Senior Director Client Services

Contact Sandy Speer

Steven Hu

Director of R & D

Contact Steven Hu

View All Dottie Koulermos's Colleagues
Dottie Koulermos's Contact Details
HQ
631-924-1135
Location
Company
Chembio Diagnostics
Dottie Koulermos's Company Details
Chembio Diagnostics logo, Chembio Diagnostics contact details

Chembio Diagnostics

Medford, NY, US • 100 - 249 Employees
Medical Equipment

About Chembio Diagnostics:Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com.About the DPP Rapid Test Platform:Chembio's proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio's easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.Chembio's portfolio of DPP-based point-of-care tests with FDA regulatory approvals include the DPP HIV-Syphilis System (PMA approved), DPP HIV 1/2 Assay (PMA approved and CLIA waived), DPP Zika IgM System (510(k)), and DPP Ebola Antigen System (EUA). Additionally, DPP-based tests have received regulatory approvals from the World Health Organization, CE-Mark, Agência Nacional de Vigilância Sanitária (ANVISA), and other global organizations.

B2B Biotechnology Healthcare Medical Devices Medical Diagnostics Pharmaceuticals Medical Equipment Medical and Hospital Equipment Research Development Business Services
Details about Chembio Diagnostics
Frequently Asked Questions about Dottie Koulermos
Dottie Koulermos currently works for Chembio Diagnostic Systems, Inc..
Dottie Koulermos's role at Chembio Diagnostic Systems, Inc. is Credit Manager.
Dottie Koulermos's email address is ***@chembio.com. To view Dottie Koulermos's full email address, please signup to ConnectPlex.
Dottie Koulermos works in the Medical Devices industry.
Dottie Koulermos's colleagues at Chembio Diagnostics are Annette Ortiz, Ehsan Bagherzadeh, Richard Eberly, Chuck Caso, Melissa Gallagher, Sandy Speer, Steven Hu and others.
Dottie Koulermos's phone number is 631-924-1135
See more information about Dottie Koulermos